Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
20 October 2016
Header
Header image
News

News

EFPIA and EBE Welcome NOR-SWITCH Results as a Valuable Step Forward
19 October 2016

EFPIA and EBE welcome the results of the NOR-SWITCH study on biosimilar switching* and acknowledge its preliminary results as a step in the right direction [...] Read more

Events calendar

Events Calendar

EFPIA Health Collaboration Summit 2016 - A Healthier Future for Europe
From 09/11/2016 to 10/11/2016 (Brussels)

The event will bring together patient organisation representatives, healthcare professionals and industry leaders from across Europe to encourage dialogue and share best practice.

This year we will be focusing on the challenges and opportunities in developing a more outcomes-driven, sustainable approach to healthcare in Europe as well as optimal patient engagement throughout the lifecycle of a medicine.

Read more

Events Calendar

Optimising the Development of ATMPs to Meet Patient Needs - The fifth annual regulatory conference organised by the European Biopharmaceutical Enterprises (EBE) in collaboration with the European Medicines Agency (EMA)
On 16/12/2016 (London, UK)

Europe is a world-leader in the development of cutting edge Advanced Therapies Medicinal Products (ATMPs) including gene therapies. This conference, organised in collaboration with the EMA, will feature a gathering of international thought-leaders who will highlight initiatives to improve the access to ATMPs for patients, as well as outline the needs for their development and commercialisation within the EU.

For more information on the programme and to register, click here.

Read more

Events Calendar

pharmacogenomics: a tool for precision medicine
On 07/11/2016 (London, UK)

If you are interested in finding out about how precision medicine is set to revolutionise medical practice, do not miss this event!

The meeting will:

  • Introduce healthcare professionals to the concept of pharmacogenomics
  • Provide a realistic overview of the likely impact of pharmacogenomics in modern medicine
  • Share speciality-based experience of the role of pharmacogenomics in stratifying treatments to individual patients
  • Explain how stratification in precision medicine can be achieved

The event is organized by the Medical Genetics Section of The Royal Society of Medicine

Read more

Events Calendar

FT Global Pharmaceutical and Biotechnology Conference
From 15/11/2016 to 16/11/2016 (London, UK)

The FT Global Pharmaceutical and Biotechnology Conference, now in its 34th successful year, brings together life science companies, their health industry counterparts and emerging new industry entrants to review the key challenges facing the industry and the business models and transformation strategies that will be needed to survive and thrive in an industry in flux.

Transformational shifts in healthcare markets herald challenges as well as opportunities ahead for the global life science industry. Considerations around value and outcomes of drug and other medical interventions are becoming a part of the fabric of the industry as health technology assessment and integrated care models gain traction in a growing number of markets.

For more information, click here.

Read more

What we are reading

What we are reading

IMI SAFE-T and C-Path PSTC Obtain Regulatory Support For New Liver Safety Biomarkers
20 October 2016 (IMI SAFE-T)

The Innovative Medicines Initiative (IMI) SAFE-T (Safer and Faster Evidence Based Translation) Consortium and The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) each issued a Biomarker Letter of Support for new liver safety biomarkers investigated by the SAFE-T Drug-Induced Liver Injury Work Package, and the Predictive Safety Testing Consortium’s (PSTC) Hepatotoxicity Working Group. Research work was supported by the Drug-Induced Liver Injury Network (DILIN) in the US, an expert network established by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail